Glyburide for the treatment of gestational diabetes mellitus.

Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 3

Abstract

Insulin is the traditional treatment for gestational diabetes mellitus (GDM) unresponsive to dietary interventions. Until recently, oral hypoglycemic drugs had been contraindicated due to concerns regarding teratogenicity and the possibility of neonatal hypoglycemia. In contrast to other sulfonylurea drugs, in vitro and in vivo investigations have demonstrated very low transplacental transport of glyburide to the fetal circulation. The mechanisms preventing glyburide from crossing the human placenta are not completely understood. A combination of extremely high protein binding and a relatively short elimination half-life might partially explain it. It has also been demonstrated that glyburide is effluxed from the fetal to the maternal circulation by the breast cancer resistance protein (BRCP) and the human multidrug resistance protein 3 (MRP3). Since 2000, several studies have reported an 80-85% success rate of glyburide treatment. However, some authors have noticed glyburide-related increased risk of preeclampsia, macrosomia, neonatal hypoglycemia, admission to a neonatal intensive care unit and need for phototherapy. These possible maternal as well as neonatal adverse outcomes warrant further investigations. Until that time, the use of glyburide should remain inadvisable in pregnancy.

Authors and Affiliations

Zaneta Kimber-Trojnar, Beata Marciniak, Bozena Leszczyńska-Gorzelak, Marcin Trojnar, Jan Oleszczuk

Keywords

Related Articles

CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice.

Diabetes causes changes in the myocardium, which are often called diabetic cardiomyopathy. This condition has been extensively investigated in animal models with high glucose levels. Nevertheless, it has not been investi...

Inhibition of voltage-gated K(+) channels and Ca(2+) channels by diphenidol.

Background: Although diphenidol has long been deployed as an anti-emetic and anti-vertigo drug, its mechanism of action remains unclear. In particular, little is known as to how diphenidol affects neuronal ion channels....

Melatonin in experimental seizures and epilepsy.

Although melatonin is approved only for the treatment of jet-lag syndrome and some types of insomnia, clinical data suggest that it is effective in the adjunctive therapy of osteoporosis, cataract, sepsis, neurodegenerat...

Chronic exercise increases sensitivity to the conditioned rewarding effects of cocaine.

The purpose of this study was to determine whether chronic exercise alters sensitivity to the conditioned rewarding effects of cocaine. Female rats were obtained at weaning and randomly assigned to either sedentary or ex...

X-linked inhibitor of apoptosis protein regulates human interleukin-6 in umbilical vein endothelial cells via stimulation of the nuclear factor-kappaB and MAP kinase signaling pathways.

X-linked inhibitior of apoptosis (XIAP) is known as a potent inhibitor of apoptosis, but more recently has been shown to also act as a modulator of the nuclear factor kB (NF-kappaB) signaling pathway. To investigate whet...

Download PDF file
  • EP ID EP128981
  • DOI -
  • Views 69
  • Downloads 0

How To Cite

Zaneta Kimber-Trojnar, Beata Marciniak, Bozena Leszczyńska-Gorzelak, Marcin Trojnar, Jan Oleszczuk (2008). Glyburide for the treatment of gestational diabetes mellitus.. Pharmacological Reports, 60(3), 308-318. https://europub.co.uk/articles/-A-128981